Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer.
Thorac Cancer. 2024 Apr 11. doi: 10.1111/1759-7714.15304. Online ahead of print.
Thorac Cancer. 2024.
PMID: 38602166
Free article.
Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes.
Kobayashi N, Miura K, Kaneko A, Matsumoto H, Somekawa K, Hirose T, Kajita Y, Tanaka A, Teranishi S, Sairenji Y, Kawashima H, Yumoto K, Tsukahara T, Fukuda N, Nishihira R, Kudo M, Miyazawa N, Kaneko T.
Kobayashi N, et al. Among authors: sairenji y.
Cancers (Basel). 2023 Oct 31;15(21):5248. doi: 10.3390/cancers15215248.
Cancers (Basel). 2023.
PMID: 37958421
Free PMC article.
Item in Clipboard
Coexistence of IgG4-Related Disease and Reactive Granuloma to Paraffin Plombage.
Isoda A, Sairenji Y, Mihara M, Iriuchishima H, Saito A.
Isoda A, et al. Among authors: sairenji y.
Cureus. 2023 Jun 19;15(6):e40620. doi: 10.7759/cureus.40620. eCollection 2023 Jun.
Cureus. 2023.
PMID: 37476122
Free PMC article.
Item in Clipboard
Two cases of follicular lymphoma with MYC gene abnormalities that presented with bone marrow necrosis.
Miyazawa Y, Takei H, Kobayashi N, Akashi N, Sairenji Y, Sugisaki M, Naito C, Ishikawa T, Shimizu H, Ishizaki T, Yokohama A, Tsukamoto N, Yoshida Y, Matsumura N, Takayama Y, Handa H.
Miyazawa Y, et al. Among authors: sairenji y.
J Clin Exp Hematop. 2022 Dec 28;62(4):208-216. doi: 10.3960/jslrt.22004. Epub 2022 Oct 20.
J Clin Exp Hematop. 2022.
PMID: 36261333
Free PMC article.
Item in Clipboard
Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies.
Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Tsuchiya K, Miura K, Sairenji Y, Kinoshita N, Ujiie M, Kutsuna S, Ishizaka Y, Mitsuya H, Ohmagari N.
Inada M, et al. Among authors: sairenji y.
J Infect Chemother. 2021 Jul;27(7):1063-1067. doi: 10.1016/j.jiac.2021.04.017. Epub 2021 Apr 24.
J Infect Chemother. 2021.
PMID: 33962861
Free PMC article.
Item in Clipboard
Cite
Cite